QIAGEN powered by
Application Note: Developing a robust, automated, and streamlined clinical NGS workflow for hematological malignancies

QIAGEN Digital Insights Monday, July 6, 2020

Next-generation sequencing (NGS) has transformed the field of oncology. Early successes in identifying and targeting oncogenic drivers of solid tumors…

Using liquid biopsy to guide clinical trial enrollment for patients with cancer

QIAGEN Digital Insights Monday, July 8, 2019

Investigators in the UK are using QIAGEN Clinical Insight (QCI) to identify clinically actionable mutations from blood-based sequencing results On…

ESHG 50th Anniversary

QIAGEN Digital Insights Tuesday, May 2, 2017

This year ESHG is celebrating it’s 50th anniversary in beautiful Copenhagen! Come and meet us at booths 540 and 542 and…

A look back at ASHG 2016

QIAGEN Digital Insights Tuesday, November 8, 2016

ASHG 2016 was an exciting event for us. We loved the beautiful city of Vancouver, BC, and our calendars were…

Analysis and interpretation of cell free DNA

QIAGEN Digital Insights Thursday, April 21, 2016

Part four of our webinar series on liquid biopsies:Circulating cell-free DNA purification, sequencing and data interpretation Identification and monitoring of cancer…

Streamlined bioinformatics for RNA sequencing of liquid biopsies

QIAGEN Digital Insights Thursday, April 14, 2016

New, powerful bioinformatics tool: The RNA-Seq Explorer Solution Today we announced our new RNA-Seq Explorer Solution — a powerful bioinformatics…

Liquid biopsies show promise

QIAGEN Digital Insights Tuesday, April 5, 2016

Liquid biopsies show promise for cancer research, but technical challenges remain Preparing for this year’s annual meeting of the American…

Circulating cfDNA purification, sequencing and data interpretation

QIAGEN Digital Insights Monday, February 29, 2016

Webinar series on liquid biopsyCirculating cell-free DNA purification, sequencing and data interpretation Identification and monitoring of cancer mutations of circulating…

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.